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We have previously shown that mutations of CD14 or TLR4 impair type I interferon (IFN) production and macrophage survival during
infection with vesicular stomatitis virus (VSV). We now report that VSV glycoprotein G (gpG) is essential for the induction of a previously
unrecognized CD14/TLR4-dependent response pathway in which the adapter TRAM has predominant importance, absent any need for MyD88 or
Mal, and with only a partial requirement for TRIF. Downstream of TRAM, IRF7 activation leads to a type I IFN response. The pathway is utilized
by myeloid dendritic cells (mDCs) and macrophages rather than plasmacytoid DCs. This new mode of TLR4 signal transduction, which does not
stimulate NF-κB activation, reveals the importance of viral protein recognition by mDCs and shows that TLR4 can drive qualitatively different
events within the cell in response to different ligands.
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Toll-like receptor 4 (TLR4) is best known as the transmem-
brane component of the mammalian LPS sensor (Poltorak et al.,
1998), reviewed in Beutler et al. (2006). However, it is also well
placed to respond to viral infection. Like TLRs 3, 7, 8, and 9,
which sense nucleic acids (Alexopoulou et al., 2001; Heil et al.,
2004; Hemmi et al., 2000; Lund et al., 2004) and are known to
participate in defense against viral infections (Alexopoulou et al.,
2001; Krug et al., 2004; Tabeta et al., 2004), TLR4 is capable of⁎ Corresponding authors. P. Georgel is to be contacted at Laboratoire
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doi:10.1016/j.virol.2006.12.032stimulating the production of type I IFNs (Hoebe et al., 2003;
Yamamoto et al., 2003), which in many viral infections seem to
be secreted primarily by IFN-producing cells (Diebold et al.,
2003) (IPCs), also called plasmacytoid dendritic cells (pDCs).
TLR4 utilizes four adapter proteins to signal, and until now,
these adapters have been believed to operate in functional pairs
(MyD88 with Mal, and TRIF with TRAM). The IFN response
has been thought to depend strictly upon activation of the TRIF/
TRAM adapter pair (Fitzgerald et al., 2003), reviewed in
Beutler et al. (2006), and where responses to LPS are
concerned, TRIF and TRAM are recruited only in the presence
of CD14; hence the LPS receptor can signal in two qualitatively
distinct modes (utilizing either MyD88/Mal only or MyD88/
Mal and TRIF/TRAM) (Jiang et al., 2005). In the absence of
MyD88 and TRIF, it has been thought that both arms of the
TLR4 signaling pathway are inactivated along with signaling
from all other TLRs, as well as the IL-1 and IL-18 receptors
(Hoebe et al., 2003; Yamamoto et al., 2003).
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signals in a CD14-dependent, TLR4-dependent manner to elicit
production of type I IFN (Jiang et al., 2005). We now show that
the viral trigger is the envelope glycoprotein G (gpG). gpG
activates a third and previously unknown signaling pathway
downstream from TLR4. Represented chiefly in myeloid
dendritic cells (mDCs) rather than pDCs, the new pathway
does not activate NF-κB. It is fully dependent upon the adapter
TRAM, only partially dependent upon TRIF, and independent of
Mal and MyD88. TRAM recruitment in turn activates IRF7,
leading to type I IFN production.
Results
The viral gpG activates the TLR4–CD14 complex to induce a
type I IFN response, but does not activate NF-κB
Having earlier established that TLR4 and CD14 are essential
components of a pathway for response to VSV, each required
for type I IFN-mediated survival of macrophages infected with
the virus ex vivo (Jiang et al., 2005), we sought to identify the
viral component recognized by the host. We noted that virusFig. 1. Ifnb1 gene activation mediated by VSV gpG is CD14-dependent. Gene expres
from wild-type (left panel) or heedless (right panel) naive macrophages (ctle) or stim
(MLVVSVgp) and MLV pseudotyped with the LFV glycoprotein (MLVLFVgp).
expression was normalized relative to actin transcripts. * indicates P<0.05 and **
particles.inactivated by UV irradiation was also capable of inducing
Ifnb1 gene transcription, albeit at a lower level when compared
to intact, live virus (data not shown); hence, dsRNA produced
during viral replication of the ssRNA virus was deemed an
unlikely candidate. We reasoned that surface gpG would be a
likely activator, given its accessibility to TLR4 of the host. To
test the importance of gpG while avoiding any possibility of
LPS contamination, we produced a pseudotyped murine
leukemia virus (MLV), expressing either VSV gpG or gpG
from Lassa fever virus (LFV; an arenavirus). Peritoneal
macrophages isolated from wild-type (C57BL/6) or CD14-
deficient (heedless) mice were exposed to VSV, MLV core
particle, MLV-gpGVSVor MLV-gpGLFV (Figs. 1A and B). VSV
itself is capable of inducing IFNβ through both CD14-
dependent and CD14-independent processes. However, only
MLV-gpGVSV (and not MLV-gpGLFV nor MLV core particles)
is able to induce Ifnb1 gene activation in a CD14-dependent
manner, revealing that VSV gpG possesses activating properties
of a CD14-dependent response pathway. VSV infection also
stimulates upregulation of the Il-6 gene, which is not observed
when macrophages are stimulated by MLV-gpGVSV. IL-6 gene
activation is known to be NF-κB dependent, suggesting that thesion was measured by semi-quantitative RT-PCR performed on mRNA isolated
ulated (for 20 h) with VSV, MLV core, MLV pseudotyped with the VSV gpG
(B) The same samples were subjected to real-time quantitative PCR. Gene
P<0.01. MLVVSVgp data were compared to those obtained with MLV core
306 P. Georgel et al. / Virology 362 (2007) 304–313MLV-gpGVSVactivated pathway is directed toward activation of
type I IFN production and not toward the activation of NF-κB
dependent cytokine production. This result extends our
previous observation (Jiang et al., 2005) that VSV infection
does not induce IκB phosphorylation.
We further characterized the transcriptional response of VSV-
infected cells and showed that CD14-deficient (hdl) as well as
Tlr4 mutant (HeJ) macrophages have a pronounced defect in
transcriptional activation of Irf7, consistent with the conclusion
that IRF7 is responsible for TLR4-dependent, CD14-dependent
type I IFN gene activation (Fig. 2A).
Ifnb1 gene transcription was augmented in Cd14hdl and
Tlr4Lps mutant cells following stimulation by VSV, beyond
levels observed in wild-type cells (Figs. 2A and B).
Nonetheless, the extreme VSV susceptibility of macrophages
with genetic lesions in the CD14/TLR4 signaling axis (Jiang
et al., 2005) is mirrored by susceptibility of mutant mice
infected with VSV by intravenous inoculation. C3H/HeJ mice
showed markedly enhanced mortality as compared to C3H/
HeN mice (P<0.0001; Fig. 2C). To investigate in more detail
the discrepancy between undetectable IFN production at the
protein level (upon the bio-assay used in this study or during
ELISA quantification; Jiang et al., 2005) and high transcrip-
tional activity of the Ifnb1 gene in VSV-infected macrophages
isolated from Cd14 and Tlr4 mutant mice, we performed
polysome analysis after sucrose gradient separation of the
different mRNA species (Pillai et al., 2005). As seen in Fig. 3,
polysomes isolated from VSV-infected wild-type macrophages
(C57BL/6, panel A) are detected in fractions 5–9 as judged by
the peak of vsg-g transcripts. The same fractions also contain
detectable amounts of actin and Ifnb1 mRNAs. In contrary, the
same analysis performed on mRNAs isolated from heedless
macrophages (panel B) indicates that actin and Ifnb1 transcripts
are mostly present in low-sucrose fractions (fractions 2–5),
indicating that these mRNAs are poorly translated. This analysis
demonstrates that high viral replication in the susceptible Cd14Fig. 2. CD14 and TLR4 are essential for IRF7 transcriptional activation and resistanc
mutant (hdl, C3H/HeJ) macrophages prior to (−) or 20 h after (+) VSV infection
transcripts. *P<0.05. C. Survival curves of control (C3H/HeN) and Tlr4-mutant (Cmutant macrophages favors viral gene expression and lowers
cellular mRNA translation, including translation of the
immunologically important mRNA encoding IFNβ.
VSV-dependent TLR4 activation triggers a specific signaling
cascade
LPS-induced TLR4 signaling involves recruitment of
MyD88/Mal and TRIF/TRAM heterodimers, and the selective
activation of type I IFN production by VSV gpG suggested
selective activation of the TRIF/TRAM pathway. Surprisingly
in view of their functional association with one another,
TRAM was far more important for macrophage resistance to
VSV (20% survival of TRAM-deficient cells vs. 70% survival
of C57BL/6 cells; P<0.001) than TRIF (40% survival,
C57BL/6 vs. TrifLps2, P<0.05, Fig. 4A). Moreover, a high
level of VSV-gpG transcription was detected in the TRAM-
deficient cells, reflecting uncontrolled viral replication (Fig.
4B). VSV-dependent activation of the Irf7 gene was impaired
in TRAM-deficient macrophages (as judged by semi-quanti-
tative PCR experiment illustrated in Fig. 4B), and confirmed
by real-time quantitative PCR (P<0.05 between wild-type and
Tram-deficient macrophages, Fig. 4C) thus establishing a
specific VSV-responsive TLR4→TRAM→IRF7 pathway. As
observed in Tlr4- and Cd14-mutant macrophages, TRAM-
deficient cells exhibit Ifna and -b1 gene transcription when
infected with intact VSV (Figs. 4B and C), but not when
macrophages are exposed to pseudoviruses expressing the VSV
gpG (Fig. 4D). Finally, we observed that macrophages from 3d
homozygotes (in which signaling via TLRs 3, 7 and 9 is
abolished (Tabeta et al., 2006)) and from mice lacking TLR3 are
fully resistant to VSV infection (Fig. 5A). Further, chloroquine
and 2-aminopurine fail to increase macrophage susceptibility
(Fig. 5B). These observations exclude TLRs 3, 7, and 9 as well
as PKR as important contributors to VSV resistance in
macrophages.e to VSV infection. (A) RT-PCR performed on control (C57BL/6, C3H/HeN) or
. (B) Measurement of Ifnb1 transcripts by real-time PCR normalized to actin
3H/HeJ) mice infected by i.v. injection of VSV.
Fig. 3. Decreased translation of cellular mRNAs in VSV-infected susceptible heedless macrophages. Total mRNA from control (C57BL/6, panel A) or CD14 mutant
(heedless, panel B) were isolated 18 h after VSV infection. After centrifugation on a sucrose gradient, mRNA from the different fractions was quantified (top panel)
and subjected to reverse transcription followed by PCR detection of actin, vsv-g and Ifnb1 transcripts (medium panel). PCR products were quantified (in arbitrary
units, a.u) and plotted on the lower panel.
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VSV
Plasmacytoid dendritic cells (pDC) are considered to be the
main source of type I IFN during viral infection (Colonna et al.,
2002; Diebold et al., 2003). However, in a first set of
experiments we determined that myeloid (GM-CSF derived)
dendritic cells (mDC) are highly resistant to VSV infection,
whereas FLT3-derived plasmacytoid dendritic cells (pDC) are
comparatively susceptible (Fig. 6A). The resistance of mDC to
VSV infection is correlated with type I IFN secretion by these
cells in response to viral stimulation (Fig. 6B) and with low viral
replication (Fig. 6C), while FLT-3L derived pDC support VSV
replication to high titers and produce no detectable type I IFN.
To identify a molecular difference between these two cell
populations, we performed a series of semi-quantitative RT-
PCR experiments to follow the expression of several genes
potentially involved in viral resistance. As shown in Fig. 6D,
both cell types show induction of Ifnb1 gene transcription, but
only the FLT-3L-derived DCs exhibit a high level of transcriptsencoding VSV gpG, consistent with the high viral titer observed
in these infected cells. Strikingly, strong and sustained induction
of IRF7 mRNA is observed in VSV-infected mDC and cannot
be detected in FLT-3L-derived dendritic cells.
To precisely measure type I IFN mRNA induction, we
performed quantitative PCR on Ifna4 (not shown) and Ifnβ1
transcripts. The results presented in Fig. 6E are in agreement
with our previous semi-quantitative RT-PCR experiments and
show that both cell types respond to VSV by activating Ifnb1
gene transcription; hence, the difference in IFN production
cannot be explained on the basis of a difference in transcrip-
tional activation, and must be sought at the post-transcriptional
level, as suggested by our polysome analysis of heedless
macrophages (see above).
Because FLT3-L induced cells constitute a heterogeneous
population, in a second series of experiments we used magnetic
beads to separated B220− from B220+ cells (Fig. 7A) which
have distinct properties and give rise to different mature DC
populations in vivo (Brawand et al., 2002; Diao et al., 2004).
We observed striking differences in the susceptibility of these
Fig. 4. TLR4-dependent signal transduction upon VSV infection requires only the adaptor TRAM. (A) Measurement of the survival of peritoneal macrophages isolated
from control (C57BL/6) and adaptor-deficient mice 40 h after VSV infection (m.o.i 1 and 10). One-way ANOVA test was used to calculate the significance
(**P<0.001, *P<0.05). (B) Gene expression analysis by RT-PCR performed on mRNA prepared from control (−) or VSV-infected (+) macrophages isolated from
mice of the indicated genotypes. (C) Quantitative real-time PCR analysis of Ifna4, Ifnb1 and Irf7 transcripts in VSV-infected macrophages isolated from mice of the
indicated genotypes. Statistical significance of the difference of Irf7 expression between control and TRAM-deficient cells was assessed by one-way ANOVA test
(*P<0.05). (D) Macrophages isolated from the wild-type (C57BL/6) and adaptor-deficient mice were incubated without (−) or in the presence (+) of pseudoviruses
expressing the VSV gpG (MLVVSVgp). α-actin and Ifnb1 gene expression were followed by RT-PCR.
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cells permit high viral replication, as judged by viral RNA
amplification measured by real-time quantitative PCR (Fig.
7B), B220+ cells are totally resistant and only a limited amount
of viral transcripts can be detected 18 h after VSV infection.
Again, GM-CSF-derived cells show a moderate level of viral
genome amplification. B220+ cells represent only 15% of the
FLT3L-derived bone marrow cells. Therefore, we suspect that
our analysis of the mixed population (B220− and B220+ cells)
was biased and essentially represented the results for the B220−
subtype. Finally, we observed highest Ifnb1 mRNA expression
by B220+ cells upon viral infection and moderate Ifnb1
transcription by B220− cells, as well as GM-CSF-derived
DCs (Fig. 7C).
Discussion
We have previously shown that LPS-activated Toll-like
receptor 4 (TLR4) can signal in two distinct modes depending
upon the presence or absence of CD14, activating either
MyD88/Mal and TRIF/TRAM together, or MyD88/Mal alone,
respectively (Jiang et al., 2005). We have now described a thirdsignaling pathway, initiated by VSV gpG, that is qualitatively
distinct from either of the others. This pathway is chiefly
represented in mDCs. It entails CD14- and TLR4-dependent
recruitment of TRAM and leads to dramatic induction of IRF7,
culminating in the activation of type I IFN secretion. Notably,
IFNα and IFNβ encoding mRNAs are strongly induced by
VSV even when components of this pathway are eliminated by
mutation (Figs. 1AB and 2AB). However, IFN protein
[monitored by ELISA (Jiang et al., 2005) or with an ISRE-
reporter bioassay (this study)] is not effectively produced,
suggesting that translational or post-translational events are
involved. Certain features of the system, such as the presence of
a class II AU-rich element in the 3′ UTR of the Ifnb1 gene
(Caput et al., 1986), and the pleiotropic effects of IRF7
overexpression [not only on gene transcription but also on RNA
processing and intracellular trafficking (Barnes et al., 2004)],
might explain this observation. To determine whether Ifnb1
mRNA translation was actually suppressed, we separated
different fractions of mRNA isolated from wild-type and
Cd14 mutant macrophages infected with VSV using sucrose
gradient ultracentrifugation. This experiment clearly demon-
strated that high viral replication and gene expression in
Fig. 5. VSV resistance of macrophages is independent from TLR3 and PKR
signalling. (A) Control (C57BL/6) and mutant (3d/3d, Tlr3−/−) macrophages
survival 40 h after VSV infection at m.o.i 1, 10 and 50. (B) Quantification of
wild-type macrophage survival 40 h after VSV infection (m.o.i 1, 10, 50 and
100). Cells were untreated (control, empty square), or incubated with 10 i.u
of IFN-β (empty triangles), 10 μM chloroquine (filled triangles) or 2 mM
2-aminopurine (2-AP, filled diamonds).
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non-transcribed (not associated to ribosomes) fraction. There-
fore, despite normal expression of genes encoding type I IFN,
competition for ribosomes in the susceptible heedless macro-
phages prevents normal IFN production and secretion. These
data highlight the importance of measuring both transcripts and
proteins when studying IFN production during viral infection.
Recently, attention has been focused on the cytoplasmic
sensor of double-stranded RNA, RIG-I, in the innate immune
defense against single-stranded RNA viruses (Kato et al.,
2005b; Yoneyama et al., 2004). Several new components of
this pathway have been described, including MDA5
(Yoneyama et al., 2005) and IPS-1 (Kawai et al., 2005) [also
called MAVS (Seth et al., 2005), VISA (Xu et al., 2005) or
Cardif (Meylan et al., 2005)], all of which share with RIG-I the
capacity to induce both IRF- and NK-κB-dependent reporter
genes when over-expressed in fibroblasts. Our study showsthat, in addition to this double-stranded RNA-based detection
system, recognition of a viral protein (directly or indirectly) by
the TLR4/CD14 complex on the cell surface specifically
induces IFN production and therefore, constitutes an essential
aspect of the antiviral defense mechanism. This means of viral
sensing makes a key contribution to host defense, as indicated
by the marked susceptibility of thioglycolate-elicited peritoneal
macrophages isolated from Tlr4- or Cd14-mutant mice to VSV
infection ex vivo, and by the pronounced susceptibility of these
animals to a lethal outcome when inoculated with VSV in vivo.
The CD14/TLR4 and RIG-I pathways seem to be independent
and non-redundant at the receptor/adaptor level, but our data do
not exclude the possibility that both transduction cascades
utilize common factors, such as IRF7. In addition, both
pathways seem to function in the GM-CSF-derived dendritic
cells subpopulation, which, as recently reported (Janssen et al.,
2006) are strongly LPS responsive, whereas FLT3L-derived
cells are not. In these cells, VSV-dependent type I IFN gene
expression depends upon TLR7-MyD88 in CD11c+B220+
cells and upon RIG-I for CD11c+B220− cells (Kato et al.,
2005a). At this stage however, the reason for high viral
susceptibility of the B220− subpopulation despite Ifnb1 gene
transcription remains unexplained. Non-redundancy of TLR4-
and IPS-1/RIG-I-dependent IFN production is also illustrated at
the functional level by the high susceptibility of both IPS-1 KO
mice (Kumar et al., 2006) and Tlr4mutants to VSV (this study).
The involvement of TLR4 in viral infections has previously
been mentioned. The mouse mammary tumor virus (MMTV)
envelope glycoprotein has been shown to engage TLR4 (Burzyn
et al., 2004; Rassa et al., 2002), eliciting the production of IL-10
which permits persistent viral infection (Jude et al., 2003). In this
example, TLR4 activation is considered to be a vehicle for
evasion of innate immune responses, and the signaling pathways
that are triggered are not known. It was elsewhere reported that
purified preparations of the F-protein encoded by respiratory
syncytial virus (RSV) activate the CD14/TLR4 complex, and
that TLR4 mediates a protective response to RSV infection
(Haynes et al., 2001; Kurt-Jones et al., 2000). However, this
study did not address the role of CD14, and the conclusion that
TLR4 mediates protection was challenged by genetic experi-
ments that ascribed protection to a difference at the IL-12Rβ2
locus (Ehl et al., 2004). The present study provides strong
evidence that TLR4/CD14 engagement by VSV gpG activates a
specific anti-viral pathway. This property of the VSV envelope
protein might explain the strong stimulatory (adjuvant) effect of
fusion-active VSV gpG when incorporated within immunode-
ficiency virus-derived particles (Kuate et al., 2006). Indeed, such
modified vaccines induce a 100 fold increase in gag antibody
titers, an effect which can be at least partially mediated by the
innate immune response induced by VSV gpG on antigen
presenting cells such as myeloid DCs. Recently, viral glycopro-
tein from Herpesviridae (Human Cytomegalovirus and Herpes
Simplex Virus) have been shown to promote innate resistance
mediated by TLR2 activation (Boehme et al., 2006; Sato et al.,
2006) and HCMV proteins gB and gH physically interact with
human TLR1/2 heterodimer. Our observations, combined with
the unexpected structural homology between gB from Herpes-
Fig. 6. Differential response of bone marrow-derived dendritic cells to VSV infection. (A) Survival of GM-CSF-derived (plain line) and FLT-3L-derived (dashed line)
DC 40 h after VSV infection. (B) Type I IFN activity quantification in the supernatant of GM-CSF-DC (dark bars) and FLT-3L-DC (light bars) 8, 18 and 24 h (h) after
VSV infection (m.o.i=50). (C) Measurement of viral titers by plaque assay in the supernatant of VSV-infected DC (GMCSF-DC in dark bars, FLT-3L-DC in light
bars). (D) RT-PCR experiments for the indicated genes were performed on mRNA isolated from GM-CSF-DC and FLT-3L-DC 8, 18 and 24 h post-infection. (E) Ifnb1
mRNA measurement by real-time PCR. *P<0.05, **P<0.01.
310 P. Georgel et al. / Virology 362 (2007) 304–313viruses and gpG of VSV (Roche et al., 2006) raise the possibility
that viral detection bymultiple TLRs expressed at the cell surface
is a key element for the overall antiviral innate response. Further
additional work will be required to decipher the details of viral
envelope proteins/TLR interactions in general, and more
particularly, in the case of VSV gpG and TLR4.
Finally, we note that TLR4 orthologs are expressed in most
vertebrate species (Jault et al., 2004; Smirnova et al., 2000).
However, despite the presence of a bone fide Tlr4 gene in fish,
amphibians and reptiles, these vertebrate families are highly
resistant to LPS toxicity (Berczi et al., 1966) and are not known
to exhibit cellular responses to LPS. This raises the possibility
that TLR4 might be dedicated to viral sensing in LPS-
unresponsive species, which are known to be prey to the
Rhabdoviridae (Hoffmann et al., 2005; Monath et al., 1979).Materials and methods
Mice
Thioglycolate (TG)-elicited macrophages were harvested
3 days after TG injection by peritoneal lavage and resuspended
at 106 cells/ml. MyD88−/− mice were provided by S. Akira,
Osaka University, Osaka, and backcrossed to C57BL/6 mice.
C3H/HeN mice were obtained from Charles River and C3H/
HeJ mice from the Jackson Laboratories. Tram-deficient mice
were generated by Xenogen in a pure C57BL/6 background.
Tirap knockout animals were provided by R. Medzhitov,
Yale University, New Haven, CT. All experiments were carried
out in compliance with the rules of the TSRI Animal Use
Committee.
Fig. 7. Analysis of the FLT3L-derived dendritic cells subtypes. (A) FACS analysis of the CD11c+ cells before (pre-sort) and after (post-sort) magnetic separation of the
B220+ from B220− cells. (B) (i) Susceptibility of the different populations measured by VSV mRNA quantification (VSV G expression relative to ribosomal protein
L32) by real-time PCR 1, 5 and 18 h after viral infection. Note the different scale used for B220− and B220+ cells. (ii) All the data were plotted on a single graph. (C)
Ifnb1 expression measured by quantitative PCR (and normalized to L32 expression) before (0) and 18 h after VSV infection.
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VSV (Indiana Strain) was propagated and amplified by
infection of a monolayer of Vero cells. 24 h after infection, the
supernatant was harvested and clarified by centrifugation. Viral
titer was determined by plaque assay on Vero cells. For the
VSV cytolytic assay, 100,000 cells were plated and infected at
m.o.i 1, 10 and 50. 40 h post-infection, cell survival was
quantified by MTT staining. Recombinant Moloney murine
leukemia virus (MoMuLV) pseudotyped with gpG of VSV or
with a Lassa fever virus (LFV) glycoprotein, were produced by
transient transfection of the package cell line GP2-293 (BD
Biosciences) with the packable MoMuLV genome pLXRN,
which contains a luciferase reporter gene and a neomycin
resistance cassette (BD Biosciences). LFVGP and VSVGP
were provided in trans by co-transfection with the expression
plasmid pC-LFVGP, containing the full-length cDNA of
LFVGP Josiah, and the VSVGP expression construct pVSV-
G (BD Biosciences), respectively. Briefly, 1.2×107 GP2-293
cells were plated in poly-L-lysine coated T175 tissue culture
flasks. After 16 h, cells were co-transfected with 20 μg each of
pLXRN and pC-LFVGP or pVSV-G using calcium phosphate.
Forty hours after transfection, cell supernatants were harvested
and cleared by centrifugation for 15 min at 3000 rpm. Retroviralpseudotypes were then concentrated by ultracentrifugation at
25,000 rpm at 4 °C for 2 h using a SW28 rotor. Supernatants
were discarded after centrifugation and pellets resuspended for
16 h in DMEM, 20mMHepes, pH 7.5 at 4 °C. For determination
of titers, monolayers of HEK293 cells were infected with serial
dilutions of pseudotypes and cells subsequently subjected to
antibiotic selection using G418 according to the manufacturer’s
recommendations. Clusters of resistant cells were counted and
titers calculated.
Bio-assays
Type I IFN activity was measured with reference to a
recombinant mouse IFNβ standard using an L-929 cell line
(5.105 cells/ml) transfected with an IFN-sensitive (ISRE)
luciferase construct.
Polysome analysis
Thiglycolate-induced peritoneal macrophages from four
control (C57BL/6) or mutant (heedless) mice were pooled,
plated in 10 cm dishes and infected with VSVwith a multiplicity
of infection of 10. After 18 h, cells were harvested, washed in
cold PBS containing 100 μg/ml cycloheximide and incubated on
312 P. Georgel et al. / Virology 362 (2007) 304–313ice for 5 min. After 2 washes in cold PBS, cell lysis was realized
with hypotonic buffer containing 0.5% deoxycholate, 0.5%
Triton X-100 and 120 U/ml of Rnasin (Promega). Lysates were
centrifuged for 8 min at 3000×g at 4 °C and supernatants were
then layered onto 10–50% sucrose gradients and spun in an
SW40 rotor (Beckman) at 36,000 rpm for 2 h at 4 °C. Fourteen
800 μl fractions were collected and RNA was extracted with
phenol/chloroform and precipitated with ethanol. RNA samples
were treated with DNaseI, extracted again with phenol/chloro-
form, precipitated and solubilised in 20 μl RNase free water.
Following quantification at O.D. 260 nm, 2 μl of each fraction
were used for reverse transcription reactions. Actin, vsv-g and
Ifnb1 cDNAs were PCR amplified (30 cycles in all cases, except
for vsv-g in control macrophages which required 40 cycles for
detection) and 4 μl were loaded on agarose gels.
Bone marrow-derived dendritic cell preparation
Bone marrow cells harvested from 2 femurs of a wild-type
mouse were plated at a concentration of 106 cells/ml in IMDM
containing 10% FCS and 2% Penicillin/Streptomycin. One flask
was supplemented with human FLT-3L (200 ng/ml) and
incubated at 10% CO2 for 9 days and the other was
supplemented with mouse GMCSF (5 ng/ml) and incubated at
5% CO2. B220+ cells were isolated by positive selection using
MACS microbeads (Miltenyi Biotec, Auburn, CA). Cell purity
after positive selection was 97% and viability was >97% as
determined by FACS analysis using B220-FITC and 7-AAD.
Reverse transcription and PCR
2 μg of total mRNA were used according to the
manufacturer’s recommendations (Ambion) in a 20 μl reaction
volume for reverse transcription. 1 μl of RT reaction was used
for each PCR whose number of cycles was optimized to avoid
saturation (25 for Irf-7, 30 for all the others primer pairs). 3 μl of
reaction were loaded on agarose gels.
Quantitative PCR
Quantitative Real-time PCR was performed in a PE
Biosystems Gene-Amp 5700 thermocycler using Bio-Rad
SyBr Green detection protocol as outlined by the manufac-
turer. Briefly, 12 ng of total complementary DNA, 50 nM of
each primer and 1× SyBr Green mix were used in a total
volume of 25 μl. Actin and L32 transcripts were used as
internal normalization controls.Primers: Ifna4 forward: 5′ CCT GGT AAT GAT GAG CTA CTA CTG GT
Ifna4 reverse: 5′ ATT TCT TCC AGG ACT GTC AAG GC
Ifnb1 forward: 5′ TCC AAG AAA GGA CGA ACATTC G
Ifnb1 reverse: 5′ TGA GGA CAT CTC CCA CGT CAAStatistical analysis
Data were analyzed using ANOVA test with GraphPad
software.Acknowledgments
This work was supported by the NIH, Grant AI054523. PG
was supported by an EMBO short-term fellowship and
acknowledges financial support from la Ligue contre le cancer
and Fondation pour la Recherche Médicale.References
Alexopoulou, L., Holt, A.C., Medzhitov, R., Flavell, R.A., 2001. Recognition of
double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
Nature 413, 732–738.
Barnes, B.J., Richards, J., Mancl, M., Hanash, S., Beretta, L., Pitha, P.M., 2004.
Global and distinct targets of IRF-5 and IRF-7 during innate response to
viral infection. J. Biol. Chem. 279, 45194–45207.
Berczi, I., Bertok, L., Bereznai, T., 1966. Comparative studies on the toxicity of
Escherichia coli lipopolysaccharide endotoxin in various animal species.
Can. J. Microbiol. 12, 1070–1071.
Beutler, B., Jiang, Z., Georgel, P., Crozat, K., Croker, B., Rutschmann, S., Du,
X., Hoebe, K., 2006. Genetic analysis of host resistance: Toll-like receptor
signaling and immunity at large. Annu. Rev. Immunol. 24, 353–389.
Boehme, K.W., Guerrero, M., Compton, T., 2006. Human cytomegalovirus
envelope glycoproteins B and H are necessary for TLR2 activation in
permissive cells. J. Immunol. 177, 7094–7102.
Brawand, P., Fitzpatrick, D.R., Greenfield, B.W., Brasel, K., Maliszewski, C.R.,
De, S.T., 2002. Murine plasmacytoid pre-dendritic cells generated from Flt3
ligand-supplemented bone marrow cultures are immature APCs. J. Immunol.
169, 6711–6719.
Burzyn, D., Rassa, J.C., Kim, D., Nepomnaschy, I., Ross, S.R., Piazzon, I.,
2004. Toll-like receptor 4-dependent activation of dendritic cells by a
retrovirus. J. Virol. 78, 576–584.
Caput, D., Beutler, B., Hartog, K., Thayer, R., Brown-Shimer, S., Cerami, A.,
1986. Identification of a common nucleotide sequence in the 3′-untranslated
region of mRNA molecules specifying inflammatory mediators. Proc. Natl.
Acad. Sci. U.S.A. 83, 1670–1674.
Colonna, M., Krug, A., Cella, M., 2002. Interferon-producing cells: on the front
line in immune responses against pathogens. Curr. Opin. Immunol. 14,
373–379.
Diao, J., Winter, E., Chen, W., Cantin, C., Cattral, M.S., 2004. Characterization
of distinct conventional and plasmacytoid dendritic cell-committed
precursors in murine bone marrow. J. Immunol. 173, 826–833.
Diebold, S.S., Montoya, M., Unger, H., Alexopoulou, L., Roy, P., Haswell, L.E.,
Al-Shamkhani, A., Flavell, R., Borrow, P., 2003. Viral infection switches
non-plasmacytoid dendritic cells into high interferon producers. Nature 424,
324–328.
Ehl, S., Bischoff, R., Ostler, T., Vallbracht, S., Schulte-Monting, J., Poltorak, A.,
Freudenberg, M., 2004. The role of Toll-like receptor 4 versus interleukin-12
in immunity to respiratory syncytial virus. Eur. J. Immunol. 34, 1146–1153.
Fitzgerald, K.A., Rowe, D.C., Barnes, B.J., Caffrey, D.R., Visintin, A., Latz, E.,
Monks, B., Pitha, P.M., Golenbock, D.T., 2003. LPS-TLR4 signaling to
IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp.
Med. 198, 1043–1055.
Haynes, L.M., Moore, D.D., Kurt-Jones, E.A., Finberg, R.W., Anderson, L.J.,
Tripp, R.A., 2001. Involvement of Toll-like receptor 4 in innate immunity to
respiratory syncytial virus. J. Virol. 75, 10730–10737.
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S.,
Lipford, G., Wagner, H., Bauer, S., 2004. Species-specific recognition of
single-stranded RNA via Toll-like receptor 7 and 8. Science 303,
1526–1529.
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto,
M., Hoshino, K., Wagner, H., Takeda, K., Akira, S., 2000. A Toll-like
receptor recognizes bacterial DNA. Nature 408, 740–745.
Hoebe, K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S.O., Goode, J.,
Lin, P., Mann, N., Mudd, S., Crozat, K., Sovath, S., Han, J., Beutler, B.,
2003. Identification of Lps2 as a key transducer of MyD88-independent TIR
signalling. Nature 424, 743–748.
313P. Georgel et al. / Virology 362 (2007) 304–313Hoffmann, B., Beer, M., Schutze, H., Mettenleiter, T.C., 2005. Fish
rhabdoviruses: molecular epidemiology and evolution. Curr. Top. Micro-
biol. Immunol. 292, 81–117.
Janssen, E., Tabeta, K., Barnes, M.J., Rutschmann, S., McBride, S., Bahjat,
K.S., Schoenberger, S.P., Theofilopoulos, A.N., Beutler, B., Hoebe, K., 2006.
Efficient T cell activation via a Toll-interleukin 1 receptor-independent
pathway. Immunity 24, 787–799.
Jault, C., Pichon, L., Chluba, J., 2004. Toll-like receptor gene family and TIR-
domain adapters in Danio rerio. Mol. Immunol. 40, 759–771.
Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M.,
Kalis, C., Keck, S., Galanos, C., Freudenberg, M., Beutler, B., 2005. CD14
is required for MyD88-independent LPS signaling. Nat. Immunol. 6,
565–570.
Jude, B.A., Pobezinskaya, Y., Bishop, J., Parke, S., Medzhitov, R.M.,
Chervonsky, A.V., Golovkina, T.V., 2003. Subversion of the innate immune
system by a retrovirus. Nat. Immunol. 4, 573–578.
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K.,
Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., Akira, S., 2005a. Cell
type-specific involvement of RIG-I in antiviral response. Immunity 23,
19–28.
Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K.,
Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., Akira, S., 2005b. Cell
type-specific involvement of RIG-I in antiviral response. Immunity 23,
19–28.
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K.J.,
Takeuchi, O., Akira, S., 2005. IPS-1, an adaptor triggering RIG-I- and
Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981–988.
Krug, A., French, A.R., Barchet, W., Fischer, J.A., Dzionek, A., Pingel, J.T.,
Orihuela, M.M., Akira, S., Yokoyama, W.M., Colonna, M., 2004. TLR9-
dependent recognition of MCMV by IPC and DC generates coordinated
cytokine responses that activate antiviral NK cell function. Immunity 21,
107–119.
Kuate, S., Stahl-Hennig, C., Stoiber, H., Nchinda, G., Floto, A., Franz, M.,
Sauermann, U., Bredl, S., Deml, L., Ignatius, R., Norley, S., Racz, P., Tenner-
Racz, K., Steinman, R.M., Wagner, R., Uberla, K., 2006. Immunogenicity
and efficacy of immunodeficiency virus-like particles pseudotyped with the
G protein of vesicular stomatitis virus. Virology 351, 133–144.
Kumar, H., Kawai, T., Kato, H., Sato, S., Takahashi, K., Coban, C., Yamamoto,
M., Uematsu, S., Ishii, K.J., Takeuchi, O., Akira, S., 2006. Essential role of
IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203,
1795–1803.
Kurt-Jones, E.A., Popova, L., Kwinn, L., Haynes, L.M., Jones, L.P., Tripp, R.A.,
Walsh, E.E., Freeman, M.W., Golenbock, D.T., Anderson, L.J., Finberg,
R.W., 2000. Pattern recognition receptors TLR4 and CD14 mediate response
to respiratory syncytial virus. Nat. Immunol. 1, 398–401.
Lund, J.M., Alexopoulou, L., Sato, A., Karow, M., Adams, N.C., Gale, N.W.,
Iwasaki, A., Flavell, R.A., 2004. Recognition of single-stranded RNA
viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. U.S.A. 101,
5598–5603.
Meylan, E., Curran, J., Hofmann, K.,Moradpour, D., Binder,M., Bartenschlager,
R., Tschopp, J., 2005. Cardif is an adaptor protein in the RIG-I antiviral
pathway and is targeted by hepatitis C virus. Nature 437, 1167–1172.Monath, T.P., Cropp, C.B., Frazier, C.L., Murphy, F.A., Whitfield, S.G., 1979.
Viruses isolated from reptiles: identification of three new members of the
family Rhabdoviridae. Arch. Virol. 60, 1–12.
Pillai, R.S., Bhattacharyya, S.N., Artus, C.G., Zoller, T., Cougot, N., Basyuk, E.,
Bertrand, E., Filipowicz, W., 2005. Inhibition of translational initiation by
Let-7 MicroRNA in human cells. Science 309, 1573–1576.
Poltorak, A., He, X., Smirnova, I., Liu, M.Y., Van, H.C., Du, X., Birdwell, D.,
Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli,
P., Layton, B., Beutler, B., 1998. Defective LPS signaling in C3H/HeJ and
C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088.
Rassa, J.C., Meyers, J.L., Zhang, Y., Kudaravalli, R., Ross, S.R., 2002. Murine
retroviruses activate B cells via interaction with Toll-like receptor 4. Proc.
Natl. Acad. Sci. U.S.A. 99, 2281–2286.
Roche, S., Bressanelli, S., Rey, F.A., Gaudin, Y., 2006. Crystal structure of the
low-pH form of the vesicular stomatitis virus glycoprotein G. Science 313,
187–191.
Sato, A., Linehan, M.M., Iwasaki, A., 2006. Dual recognition of herpes simplex
viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. U.S.A.
103, 17343–17348.
Seth, R.B., Sun, L., Ea, C.K., Chen, Z.J., 2005. Identification and characteriza-
tion of MAVS, a mitochondrial antiviral signaling protein that activates NF-
kappaB and IRF3. Cell 122, 669–682.
Smirnova, I., Poltorak, A., Chan, E.K., McBride, C., Beutler, B., 2000.
Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus
(TLR4). Genome Biol. 1, 1–10.
Tabeta, K., Georgel, P., Janssen, E., Du, X., Hoebe, K., Crozat, K., Mudd, S.,
Shamel, L., Sovath, S., Goode, J., Alexopoulou, L., Flavell, R.A., Beutler,
B., 2004. Toll-like receptors 9 and 3 as essential components of innate
immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad.
Sci. U.S.A. 101, 3516–3521.
Tabeta, K., Hoebe, K., Janssen, E.M., Du, X., Georgel, P., Crozat, K., Mudd, S.,
Mann, N., Sovath, S., Goode, J., Shamel, L., Herskovits, A.A., Portnoy, D.A.,
Cooke, M., Tarantino, L.M., Wiltshire, T., Steinberg, B.E., Grinstein, S.,
Beutler, B., 2006. The Unc93b1 mutation 3d disrupts exogenous antigen
presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7,
156–164.
Xu, L.G., Wang, Y.Y., Han, K.J., Li, L.Y., Zhai, Z., Shu, H.B., 2005. VISA is an
adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19,
727–740.
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H.,
Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., Akira, S., 2003. Role
of adaptor TRIF in the MyD88-independent Toll-like receptor signaling
pathway. Science 301, 640–643.
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T.,
Miyagishi, M., Taira, K., Akira, S., Fujita, T., 2004. The RNA helicase RIG-I
has an essential function in double-stranded RNA-induced innate antiviral
responses. Nat. Immunol. 5, 730–737.
Yoneyama, M., Kikuchi, M., Matsumoto, K., Imaizumi, T., Miyagishi, M.,
Taira, K., Foy, E., Loo, Y.M., Gale Jr., M., Akira, S., Yonehara, S., Kato, A.,
Fujita, T., 2005. Shared and unique functions of the DExD/H-Box helicases
RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175,
2851–2858.
